logo
Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns

Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns

CBS News13-05-2025
Weight loss drugs have transformed how Americans lose weight, including former commissioner for the U.S. Food and Drug Administration Dr. David Kessler. But, Kessler warns there are unknowns about long-term use of the drugs and how to get people off them.
"There is no end game," he said on "CBS Mornings Plus" Tuesday. "FDA allowed these medicines out without a long-term strategy."
Kessler faced unexpected weight gain while serving in his role co-leading Operation Warp Speed, the coronavirus vaccination program at the height of the pandemic, which had him working extensive hours a day at his computer.
"I turned around and found that I was 40, 50 pounds heavier," he said. He started losing weight "the traditional way with diet," but admitted it was slow.
"I actually ended up having a kidney stone, ended up in an endocrinologist office, and he said, 'Do you want to try the new GLP-1 drugs?'" he recounted. Kessler, who was studying them at the time, agreed to try them himself.
"It's a real journey," he said. "You can reclaim your health, but there are no such things as miracle pills." Kessler explores the weigh loss drug craze in his new book, "Diet, Drugs and Dopamine: The New Science of Achieving a Healthy Weight."
The drugs have provided an opportunity to "transform our health," Kessler said, explaining that belly fat has a causal effect on health issues like cardiac disease and kidney disease. But, it's just one tool in a larger journey, he said.
GLP-1 drugs condition your brain to want less food.
"They take you to the edge of nausea. Food just stays in your stomach longer ... and when food stays in your stomach longer, you're not going to want to put more food in your stomach," Kessler said.
If you stop taking the drugs, however, "that's going to fade," and you'll likely gain back the lost weight, he said.
"The premise of the drug companies, you can imagine what they want — they want you to be on this for life," Kessler said.
Currently, there isn't data on how to get off the drugs safely or how to go back on safely.
"FDA's going to have to require that data," Kessler said. "We're just running a national experiment because we don't have the data."
Some other tools needed for long-term weight loss are learning to eat better and physical activity. Kessler said the most important thing is being under good care.
"You have to have a doc, you have to have a nutritionist, a dietitian," he said. "Not everyone ... can afford that. That really concerns me."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Salad Recall Sparks Highest Risk Warning For Consumers
Salad Recall Sparks Highest Risk Warning For Consumers

Newsweek

time40 minutes ago

  • Newsweek

Salad Recall Sparks Highest Risk Warning For Consumers

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Recalls of 15 products containing tuna salad have been given the highest-alert warning by the U.S. Food and Drug Administration (FDA). The recalls relate to possible contamination with listeria monocytogenes in breadcrumbs used as an ingredient by Idaho-based company Reser's Fine Food. Albertsons, Randalls and Tom Thumb stores in Arkansas, Louisiana, Oklahoma and Texas, and Jewel Osco stores in Illinois, Indiana and Iowa issued the recalls in mid-July. The FDA classified the recalls as Class I, the highest of three levels, on August 13. Why It Matters "Listeria monocytogenes is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people and others with weakened immune systems," the FDA warned in an initial recall notice. "Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women." Stock image of a tuna salad. Stock image of a tuna salad. Getty Images What To Know Consumers who purchased these products should not eat them and are advised to either discard the items or return them to their local store for a full refund. In such cases, the FDA urges anyone who bought or received recalled products to thoroughly clean and sanitize any surfaces, utensils, or containers that may have come into contact with them, in order to reduce the risk of cross-contamination The recall products to be classified Class I are as follows: Product Description Code Information READY MEALS QUAD TUNA SALAD Jul 17 25; Jul 18 25; Jul 19 25; UPC: 21500300000 READY MEALS QUAD TUNA SALAD Jul 17 25; Jul 18 25; Jul 19 25; UPC: 21500300000 READY MEALS TUNA SALAD Jul 17 25; Jul 18 25; Jul 19 25; UPC: 29486900000 READY MEALS SUSTAINABLE TUNA SALAD CROISSANT SANDWICH Jul 17 25; Jul 18 25; Jul 19 25; UPC: 21372500000 Jewel Osco TUNA SALAD Jul 17 25; Jul 18 25; Jul 19 25; UPC: 21680700000 READY MEALS PREMIUM TUNA SALAD Jul 17 25; Jul 18 25; Jul 19 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; Jul 29 25; UPC: 21425000000 READY MEALS TUNA SALAD SNACKER TRAY Jul 17 25; Jul 18 25; Jul 19 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; Jul 29 25; UPC: 21151300000 READY MEALS TUNA SALAD CROISSANT SANDWICH Jul 16 25; Jul 17 25; Jul 18 25; Jul 23 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; UPC: 21788400000 READY MEALS TUNA SALAD OVER BED OF LETTUCE Jul 16 25; Jul 17 25; Jul 18 25; Jul 23 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; UPC: 21786400000 Randalls PREMIUM TUNA SALAD Jul 17 25; Jul 18 25; Jul 19 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; Jul 29 25; UPC: 21228800000 Randalls MINI SALAD CROISSANT 16 INCH TRAY Jul 16 25; Jul 17 25; Jul 18 25; Jul 23 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; UPC: 27841300000 Randalls MINI SALAD CROISSANT 18 INCH TRAY Jul 16 25; Jul 17 25; Jul 18 25; Jul 23 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; UPC: 27841200000 Randalls SALAD SANDWICH 12 INCH TRAY Jul 16 25; Jul 17 25; Jul 18 25; Jul 23 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; UPC: 27841500000 Randalls SALAD SANDWICH 16 INCH TRAY Jul 16 25; Jul 17 25; Jul 18 25; Jul 23 25; Jul 24 25; Jul 25 25; Jul 26 25; Jul 27 25; Jul 28 25; UPC: 27841400000 Jewel Osco CLUB SANDWICHES WITH SALAD Jul 16 25; Jul 17 25; Jul 18 25; UPC: 29125900000 "Listeria monocytogenes can survive in refrigerated temperatures and can easily spread to other foods and surfaces," the FDA warned in recall notices. No adverse reactions connected with these products had been reported when the initial recalls were issued. Anyone concerned about an injury or illness should contact a healthcare provider, the FDA added. Consumers can contact Albertsons Companies' Customer Service Center at 1-877-723-3929 Monday through Friday from 5 a.m. to 9 p.m. PST. What Happens Next The recalls remain active.

Diabetes Discovery Reduces 'Life Threatening' Complication Risk
Diabetes Discovery Reduces 'Life Threatening' Complication Risk

Newsweek

timean hour ago

  • Newsweek

Diabetes Discovery Reduces 'Life Threatening' Complication Risk

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The discovery of a new biological pathway may explain why people with type 2 diabetes are twice as prone to dangerous blood clots—putting them at risk of heart attack and stroke. This is the conclusion of researchers from the University of Sydney, who say their findings may pave the way for new treatments that reduce this danger. "People with type 2 diabetes have a higher risk of heart attacks and strokes. Part of the reason for this is that their platelets are hyper-reactive," paper author and hematologist professor Freda Passam told Newsweek. Platelets are small cell fragments found in our blood that form clots to help stop bleeding. The high levels of blood sugar seen in diabetes, however, cause biochemical changes that make them "stickier", Passam explained, so they can clot when not needed to. The hematologist continued: "Drugs like aspirin prevent platelets from clotting, but are three times less effective in people with type 2 diabetes. Understanding why platelets are more active in diabetes opens the door to develop drugs that target this newly discovered pathway." In their study, the team found that the levels of a protein called "SEC61B" is significantly increased in the platelets—the tiny blood cells that help form clots—of people with type 2 diabetes. The protein appears to disrupt calcium balance inside platelets, making them more likely to clump together and form clots, the researchers explained. The researchers found that blocking SEC61B activity with an antibiotic called anisomycin reduced platelet clumping in both human samples and animal models. Smiling woman checking her blood sugar levels. Smiling woman checking her blood sugar levels. JLco -Around 1 in 10 Americans (more than 38 million people) live with diabetes, of which 90–95 percent have type 2, which occurs when insulin doesn't work properly or there's not enough of it. While type 2 diabetes typically develops in people aged 45 and over, children, teens and young adults are increasingly developing the condition as well. "People living with type 2 diabetes are vulnerable to increased risk of blood clots," Passam said in a statement. "These exciting findings identify a whole new way to reduce this risk and help prevent life-threatening complications like heart attack and stroke." In their study, the team analyzed both human and mouse platelets, discovering that SEC61B contributes to calcium leakage from the platelets' stores, making the cell fragments more reactive. The Australia-based researchers noted that the condition is "more prevalent in Aboriginal and Torres Strait Islander peoples and in rural and regional communities." "Cardiovascular disease is a leading cause of death in this group, partly due to the heightened activity of platelets—the tiny blood cells that help form clots," they explained. "This heightened platelet sensitivity to clotting also makes traditional anti-coagulant treatments less effective in people with type 2 diabetes, limiting the options to reduce the risk of cardiovascular disease." Treatments targeting SEC61B are still in early stages. However, the researchers believe pre-clinical trials in animals could begin within 1–2 years, with potential therapies for patients likely to be available in the next decade. Do you have a tip on a health story that Newsweek should be covering? Do you have a question type 2 diabetes? Let us know via health@ Reference Kong, Y. X., Rehan, R., Moreno, C. L., Madsen, S., Zhang, Y., Zhao, H., Qi, M., Houlahan, C., Cartland, S. P., Robertshaw, D., Trang, V., Ong, F. J. L., Liu, M., Cheng, E., Alwis, I., Dupuy, A., Cielesh, M., Cooke, K. C., Potter, M., Stӧckli, J., Morahan, G., Kalev-Zylinska, M., Rondina, M. T., Schulman, S., Yang, J., Neely, G. G., Schoenwaelder, S., Jackson, S., James, D., Kavurma, M. M., Hocking, S., Twigg, S. M., Weaver, J., Larance, M., & Passam, F. H. (2025). SEC61B regulates calcium flux and platelet hyperreactivity in diabetes. Journal of Clinical Investigation.

How thyroid drugs became a MAHA flashpoint
How thyroid drugs became a MAHA flashpoint

Politico

timean hour ago

  • Politico

How thyroid drugs became a MAHA flashpoint

Driving the Day THYROID DRUG PUSHBACK — A recent FDA letter to makers and distributors of a decades-old thyroid medication has stoked outrage among a subset of pharmacists and wellness influencers linked to the Make America Healthy Again movement led by Health Secretary Robert F. Kennedy Jr. The products in question are known as desiccated thyroid extracts, which are 'the dried, ground-up thyroid glands of pigs,' according to Tenille Davis, the Alliance for Pharmacy Compounding's chief advocacy officer. The animal-derived drugs, which predate the FDA as an institution, are among the treatment options for people with an underactive thyroid, or hypothyroidism, though the agency says most patients take FDA-approved synthetic hormone replacements. But last week, the FDA informed firms that market animal-derived versions that it would take action if they continued to sell them. The agency said it received more than 500 adverse event reports from the products between 1968 and February 2025 — with a substantial increase seen between 2019 and 2020. 'FDA is committed to pursuing the first-ever approval of desiccated thyroid extract, pending results of the ongoing clinical trials. In the mean time, we will ensure access for all Americans,' FDA Commissioner Marty Makary posted on social media platform X on Thursday. The agency said it would give 'adequate time' for providers to transition patients to FDA-approved options, noting it expects them to need about 12 months. The uproar: Some wellness influencers with ties to Kennedy panned the FDA's move on social media and urged their followers to sign online petitions urging the agency to back down. Brigham Buhler, who owns the compounding pharmacy ReviveRX and is aligned with many of Kennedy's policy priorities, suggested the agency's position favors AbbVie, which makes synthetic thyroid medicines and has another candidate in clinical trials. 'Is this an example of fda working for Pharma again to create another monopoly over a drug that has been used for 100 plus years so that they can raise the prices like Pharma bro Martin [Shkreli] again?' he said in a text message. AbbVie said it would work with the agency to ensure access is not interrupted. The FDA did not respond to an interview request. 'With our ongoing clinical trials, we remain committed to these patients and their providers,' AbbVie posted Thursday on X. Why it matters: The drugs are used to prevent side effects of hypothyroidism, such as fatigue and weight gain. A doctor must closely monitor dosing because the margin between a low dose that might not be effective and a high dose that could cause side effects is small. Davis said some patients don't respond well to the synthetic drugs. While their blood panels might suggest the medication works, she said, patients continue to 'feel really crappy' until they switch to the animal-derived versions. Those people might be in the minority, Davis said, but they're still a sizeable population given the number of Americans with hypothyroidism. 'It's happened enough times where these patients aren't crazy,' she said. IT'S FRIDAY. WELCOME BACK TO PRESCRIPTION PULSE. The FDA cautioned against sunscreens that come in mousse form this week, saying they might not be effective. Send tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). AROUND THE AGENCIES VAX SAFETY GROUP IS BACK — HHS said Thursday it's bringing back a 1990s-era task force on safer childhood vaccines, fulfilling a demand made by the secretary's old colleagues at an anti-vaccine group, Lauren reports. The department is reinstating the group, which was created by the 1986 law establishing a compensation program for vaccine-injured people, 'to improve the safety, quality, and oversight of vaccines administered to American children,' HHS said in a statement. NIH Director Jay Bhattacharya will lead the effort, with leaders from the FDA and the CDC participating. An HHS spokesperson didn't specify who else from the agencies would sit on the panel. HHS Secretary Robert F. Kennedy Jr. has long questioned the safety of the modern childhood vaccination schedule, suggesting the number of shots young kids receive may contribute to myriad chronic conditions, including autism. Dozens of scientific studies have found no link between vaccines and autism. Background: The Task Force on Safer Childhood Vaccines' earlier iteration disbanded in 1998 after issuing recommendations for ways the government could support the development of safer vaccines, improve adverse event surveillance and educate the public about their benefits and risks. But the law that established the task force also directed HHS to report to Congress every two years about actions it had taken to promote safer products — a paperwork burden that the Kennedy-founded group Children's Health Defense says was never met. HHS's announcement came the day before the federal government is due to respond to CHD's May lawsuit regarding Kennedy's failure to reestablish the task force. In a deadline extension request filed last month and approved, Justice Department lawyers indicated the parties could reach a settlement. 'It took nearly 30 years for HHS to do this, but at last, we have an HHS secretary who is following the law on this vital issue,' CHD President and CEO Mary Holland said in a statement. What's next: The task force is supposed to collaborate with the Advisory Commission on Childhood Vaccines, a lesser-known federal advisory committee in the vaccine space, in developing its recommendations. The secretary can appoint up to nine ACCV voting members, evenly split among health professionals, attorneys and the general public — at least two of whom have children who were injured by a vaccine. Of the current roster, no member's term ends before July 2026, and it's unclear whether Kennedy might try to shake it up before then as he did with the CDC's independent vaccine panel. Drug Pricing LILLY'S MFN PLAY? Indianapolis-based Eli Lilly said Thursday it would raise prices on its drugs in European markets as a way to lower costs for American consumers — an apparent response to President Donald Trump's most-favored-nation pressure campaign, Lauren writes. The statement came two weeks after Trump sent letters to the leaders of major drug manufacturers — and posted them on social media — demanding they embrace most-favored-nation pricing that ties U.S. prices to lower figures paid in other wealthy nations or face unknown consequences. 'Lilly supports the administration's goal of keeping the United States the world's leading destination for biopharmaceutical research and manufacturing, and the objective of more fairly sharing the costs of breakthrough medical research across developed countries,' the company said in a statement. When asked to elaborate on how the drugmaker will achieve that goal — and which drugs may be implicated — a company spokesperson referred to the online statement. Eye on the FDA GOLD STANDARD SCIENCE? The FDA quietly posted a new staff manual laying out the 'core tenets of gold standard science' online this week, following up on an executive order from President Donald Trump in May. 'In conducting our mission to protect and promote public health, FDA must generate and evaluate science in a manner that ensures FDA will make sound, objective decisions,' the staff manual states. 'Preserving and promoting GSS is essential to ensuring that FDA's mission succeeds and our regulatory decisions advance public health.' The document says the FDA will focus on reproducibility and replicable science, transparency in its research process, communication of errors and uncertainty and encouragement of collaborative and interdisciplinary approaches in science. It also says the FDA will embrace 'a culture of constructive skepticism in science through policies and programs that emphasize critical evaluation, transparency and objectivity,' values science that includes testable hypotheses with 'explicitly defined measurable criteria for falsification,' and recognizes the value of studies that have negative results. Document Drawer FDA Commissioner Marty Makary met with Sen. Steve Daines (R-Mont.) on July 30 to discuss abortion pill mifepristone, according to newly posted public calendar disclosures. He also held an introductory meeting with Sen. Amy Klobuchar (D-Minn.) on July 31. The FDA will hold a public meeting on Sept. 19 to discuss how to advance the development of interchangeable biosimilar products. The Health Resources and Services Administration is asking for feedback on its recommendation to add Duchenne muscular dystrophy and metachromatic leukodystrophy to the Recommended Uniform Screening Panel — a step that would require most insurers to cover the screenings without cost-sharing. WHAT WE'RE READING Costco will not dispense abortion pill mifepristone at its pharmacies, Bloomberg's Jeff Green and Jessica Nix report. President Donald Trump signed an executive order Wednesday directing HHS to stock drug ingredients to help bolster domestic supply, Lauren reports.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store